This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Marsh & McLennan (MMC) Q4 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results reflect sound contributions from the Consulting segment and well-performing international operations, partly offset by escalating operating costs.
Marsh & McLennan (MMC) Q4 Earnings Top Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 5% and 4.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q4 Earnings on Jan 26: AJG, MMC and WRB
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to aid fourth-quarter results of insurers like AJG, MMC and WRB. However, an active catastrophe environment is likely to have weighed on insurers' performance.
Why Marsh & McLennan (MMC) Might Surprise This Earnings Season
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Marsh & McLennan (MMC) Sustain Its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect solid segmental performances, partly offset by elevated compensation and benefits expenses.
The Zacks Analyst Blog Highlights Exxon Mobil, Fomento Economico Mexicano, Prologis, Marsh & McLennan and Becton Dickinson
by Zacks Equity Research
Exxon Mobil, Fomento Economico Mexicano, Prologis, Marsh & McLennan and Becton Dickinson are part of the Zacks top Analyst Blog.
What's in Store for Arthur J. Gallagher (AJG) in Q4 Earnings?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) fourth-quarter results are expected to reflect new business, strong retention and renewal premium increases across its business lines.
Top Stock Reports for Exxon Mobil, Fomento Economico Mexicano & Prologis
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), Fomento Econmico Mexicano, S.A.B. de C.V. (FMX) and Prologis, Inc. (PLD).
5 Insurance Stocks Likely to Zoom Past Q4 Earnings Estimates
by Kaibalya Pravo Dey
Increasing interest rates, growing awareness, the scaling of businesses and other factors are likely to have supported the fourth-quarter performances of insurers like Marsh & McLennan, American International, Aflac, Everest Re and Voya Financial.
Why Marsh & McLennan (MMC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Marsh & McLennan (MMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Marsh & McLennan (MMC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Marsh & McLennan (MMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher (AJG) Expands in Ireland With Buyout
by Zacks Equity Research
The buyout of First Ireland Risk will help Arthur J. Gallagher & Co.'s (AJG) expand its footprint in Ireland.
The Zacks Analyst Blog Highlights Aflac, Reinsurance Group of America, Marsh & McLennan Companies, Unum Group and The Travelers Companies
by Zacks Equity Research
Aflac, Reinsurance Group of America, Marsh & McLennan Companies, Unum Group and The Travelers Companies are part of the Zacks top analyst blog.
5 Insurance Stocks to Buy Ahead of Q4 Earnings Results
by Nalak Das
Five insurance companies are set to beat on fourth-quarter earnings. These are: AFL, RGA, MMC, UNM and TRV.
Arthur J. Gallagher (AJG) Aids Health Insurance Market With JCB
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of JCB is likely to strengthen its student health insurance market expertise and fortify its presence on the West Coast.
Marsh & McLennan (MMC) Unit Buys HMS Insurance in Maryland
by Zacks Equity Research
Marsh & McLennan's (MMC) business, Marsh, can gain significantly from the HMS Insurance acquisition through its subsidiary, MMA.
Arthur J. Gallagher (AJG) Buys NEK Insurance, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of NEK Insurance is likely to support cross-selling opportunities.
Arthur J. Gallagher (AJG) Expands in Australia With Buyout
by Zacks Equity Research
The buyout of Aviation Insurance Australia is set to help Arthur J. Gallagher & Co. (AJG) expand its footprint in Australia.
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Tower Watson and Brown & Brown
by Zacks Equity Research
Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Tower Watson and Brown & Brown have been highlighted in this Industry Outlook article.
5 Insurance Brokers to Watch Amid Industry Headwinds
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, AJG, WLTW and BRO.
Arthur J. Gallagher (AJG) Expands in Midwest With Mahowald
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of Mahowald Insurance is likely to boost its footprint and capabilities in the Midwest region.
Early Q4 Earnings Results and Analyst Reports for Merck, Bristol-Myers & Deere
by Sheraz Mian
Today's Research Daily features update on the Q4 earnings season and new research reports on Merck (MRK), Bristol-Myers (BMY) and Deere (DE).
Why You Should Hold on to Marsh & McLennan (MMC) Stock for Now
by Zacks Equity Research
As economies around the world are recovering, Marsh & McLennan's (MMC) Consulting business is likely to flourish.
Arthur J. Gallagher (AJG) Expands in the Caribbean With Buyout
by Zacks Equity Research
The buyout of Global Financial Brokers Limited and its affiliate will help Arthur J. Gallagher & Co.'s (AJG) expand its footprint in the Caribbean.
Marsh & McLennan (MMC) Unit Buys McDonald Zaring in Washington
by Zacks Equity Research
Marsh & McLennan's (MMC) business, Marsh, is likely to gain from the McDonald Zaring acquisition through its subsidiary Marsh McLennan Agency.